Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 14/20 | 0.42 |
| ▸ | FAAH | O00519 | 5/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL215641 | 0.88 | MGLL (0.54) | MGLLFAAHELANEPOLBHSP90AA1 | |
| SCHEMBL2734055 | 0.84 | ELANE (0.41) | ELANEPOLBPKMPGR | |
| SCHEMBL13037674 | 0.83 | CYP2A6 (0.38) | PGR | |
| SCHEMBL6135830 | 0.78 | MGLL (0.68) | MGLLFAAHELANEPOLBHSP90AA1 | |
| SCHEMBL13720708 | 0.77 | TSHR (0.43) | TDP1 | |
| SCHEMBL3672504 | 0.76 | MGLL (0.71) | MGLLFAAHHSP90AA1PKMMAPK1 | |
| SCHEMBL2734385 | 0.76 | ALDH1A1 (0.41) | MAPK1TDP1PGR | |
| SCHEMBL2734058 | 0.76 | ALDH1A1 (0.41) | MAPK1TDP1PGR | |
| SCHEMBL2734565 | 0.73 | MEN1 (0.49) | PKMMAPK1NPSR1TDP1PGR | |
| SCHEMBL2734050 | 0.73 | MEN1 (0.49) | PKMMAPK1NPSR1TDP1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088932-B2 | Pentaaryldiamine-containing bismaleimide compound and method of producing the compound | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-01-03 | — | — | US | disclosed |
| US-20100168442-A1 | PENTAARYLDIAMINE-CONTAINING BISMALEIMIDE COMPOUND AND PRODUCING METHOD THEREOF | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168442-A1 | PENTAARYLDIAMINE-CONTAINING BISMALEIMIDE COMPOUND AND PRODUCING METHOD THEREOF | ACMSD, ALDH7A1, ADSL | MGLL 980/4885FAAH 324/4885ELANE 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.